HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

H Wittenburg Selected Research

Mesalamine (Mesalazine)

3/2012MPA: a treatment option for lymphocytic colitis and mesalamine-induced interstitial nephritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


H Wittenburg Research Topics

Disease

2Gallstones (Gallstone)
11/2014 - 07/2003
2Obesity
11/2014 - 06/2010
2Cholelithiasis
11/2014 - 07/2003
1Lymphocytic Colitis
03/2012
1Interstitial Nephritis (Tubulointerstitial Nephritis)
03/2012
1Hemorrhage
09/2011
1Fibrosis (Cirrhosis)
09/2011
1Alcoholic Fatty Liver
06/2010
1Type 2 Diabetes Mellitus (MODY)
06/2010

Drug/Important Bio-Agent (IBA)

1fibroblast growth factor 21IBA
11/2014
1ProgranulinsIBA
11/2014
1EnzymesIBA
11/2014
1ImmunosorbentsIBA
11/2014
1Fatty Acid-Binding ProteinsIBA
11/2014
1AdiponectinIBA
11/2014
1AdipokinesIBA
11/2014
1Mesalamine (Mesalazine)FDA LinkGeneric
03/2012
1Gastrointestinal Hormones (Hormones, Gastrointestinal)IBA
06/2010
1CholesterolIBA
07/2003
1Cholic AcidIBA
07/2003

Therapy/Procedure

1Ligation
09/2011
1Liver Transplantation
09/2011
1Investigational Therapies (Experimental Therapy)
06/2010